Top

Tag: drug manufacturing


Manufacturing, Research and Development

Stanford spinout forms drug delivery joint venture with Chinese biotech

January 18, 2022

Via: FiercePharma

Stanford University spinout N1 Life has formed a joint venture to further its drug delivery ambitions. The startup is teaming up with Accuredit Therapeutics to create a joint venture, Napoltec, focused on novel drug delivery systems and the progression of […]


Manufacturing, Research and Development

Samsung Biologics to Construct New Manufacturing Facility for Next-Gen Vaccines and CGT

January 18, 2022

Via: Biopharm International

Samsung Biologics announced on Jan. 12, 2022 that it plans to start building a new facility (designated Plant 5) at Songdo in Incheon, South Korea, this year. The facility will offer manufacturing for multi-modal products, including cell and gene therapies […]


Industry, Vaccines

Pfizer/BioNTech confirm new global collaboration to develop first mRNA-based shingles vaccine

January 6, 2022

Via: PMLiVE

The collaboration will see the two companies exploring new R&D and commercialisation in the hope of producing a preventative treatment for shingles – herpes zoster virus (HZV) – which is believed to impact around one in three people in the […]


FDA, Regulations

FDA Keeps New Drugs Coming

January 5, 2022

Via: Biopharm International

Despite major challenges and demands created by the coronavirus pandemic, FDA maintained a steady pace in 2021 in approving important new therapies for market, including new vaccines and treatments for COVID-19. Last year saw the Center for Drug Evaluation and […]


FDA, Regulations

Relief for AZ, Amgen as FDA okays severe asthma hope tezepelumab

December 20, 2021

Via: Pharmaphorum

Another phase 3 study supported the efficacy of the first-in-class TSLP inhibitor as an add-on treatment for people aged 12 and over with severe asthma, as did an earlier phase 2 trial, but the miss raised questions about the drug’s […]


Manufacturing, Research and Development

New Compounds Block Antimicrobial Resistance to Last Resort Antibiotics

December 14, 2021

Via: Genetic Engineering and Biotechnology News

Scientists have discovered a new potential treatment that could reverse antibiotic resistance in different Gram-negative bacteria that cause conditions including urinary tract infections, sepsis, or pneumonia. The collaborative research, headed by a team at the Ineos Oxford Institute (IOI) for […]


Industry, Pharma

Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders

November 29, 2021

Via: Pharmaphorum

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies. It will take place […]


Industry, Vaccines

Pfizer, Moderna, J&J and AstraZeneca assess omicron’s effect on their COVID-19 vaccines

November 29, 2021

Via: FiercePharma

With the new omicron strain fueling fear around the globe that the coronavirus is regaining momentum, makers of the world’s most successful vaccines are investigating whether they need to tweak their shots. Over the last few days, Moderna, Pfizer-BioNTech, Johnson […]


News

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

November 23, 2021

Via: Pharmaphorum

The French drugmaker has been enticed by an artificial intelligence (AI) algorithm developed by Chinese tech giant Baidu, which controls most of China’s search engine traffic and is sometimes referred to as the country’s Google. Less well known is that […]


News

Success of Covid Antiviral Pills Hinges on Access to Speedy and Accurate Tests

November 22, 2021

Via: Kaiser Health News

Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option […]


News

US government to pay $5.3bn for Pfizer‘s Paxlovid

November 22, 2021

Via: PMLiVE

The supply agreement will see the government receive ten million treatment courses of Paxlovid, pending regulatory approval, starting later in the year and into 2022. Paxlovid is a combination of PF-07321332 and ritonavir; PF-07321332 blocks the action of a protease […]


Industry, Pharma

Gilead pays up to retain rights to Arcus cancer drugs

November 18, 2021

Via: Biopharma Dive

The initial deal between Gilead and Arcus gave the larger drugmaker rights to an experimental drug called zimberelimab, which attacks cancers using the same mechanism as Keytruda, along with an option to license the four projects covered by Thursday’s announcement. […]